OBJECTIVE: Our objective was to determine whether endothelial-dependent vasodilation is an essential mechanism by which insulin stimulates human skeletal muscle protein synthesis and anabolism. SUBJECTS: Subjects were healthy young adults (n=14) aged 31+/-2 yr. DESIGN: Subjects were studied at baseline and during local leg infusion of insulin alone (control, n=7) or insulin plus the nitric oxide synthase inhibitor NG-monomethyl-L-arginine (L-NMMA, n=7) to prevent insulin-induced vasodilation. METHODS: We measured skeletal muscle protein metabolism with stable isotope tracers, blood flow with indocyanine green, capillary recruitment with contrast enhanced ultrasound, glucose metabolism with stable isotope tracers, and phosphorylation of proteins associated with insulin (Akt) and amino acid-induced mammalian target of rapamycin (mTOR) complex 1 (mTORC1) signaling (mTOR, S6 kinase 1, and eukaryotic initiation factor 4E-binding protein 1) with Western blot analysis. RESULTS: No basal differences between groups were detected. During insulin infusion, blood flow and capillary recruitment increased in the control (P<0.05) group only; Akt phosphorylation and glucose uptake increased in both groups (P<0.05), with no group differences; and mTORC1 signaling increased more in control (P<0.05) than in L-NMMA. Phenylalanine net balance increased (P<0.05) in both groups, but with opposite mechanisms: increased protein synthesis (basal, 0.051+/-0.006 %/h; insulin, 0.077+/-0.008 %/h; P<0.05) with no change in proteolysis in control and decreased proteolysis (P<0.05) with no change in synthesis (basal, 0.061+/-0.004 %/h; insulin, 0.050+/-0.006 %/h; P value not significant) in L-NMMA. CONCLUSIONS: Endothelial-dependent vasodilation and the consequent increase in nutritive flow and mTORC1 signaling, rather than Akt signaling, are fundamental mechanisms by which insulin stimulates muscle protein synthesis in humans. Additionally, these data underscore that insulin modulates skeletal muscle proteolysis according to its effects on nutritive flow.
OBJECTIVE: Our objective was to determine whether endothelial-dependent vasodilation is an essential mechanism by which insulin stimulates human skeletal muscle protein synthesis and anabolism. SUBJECTS: Subjects were healthy young adults (n=14) aged 31+/-2 yr. DESIGN: Subjects were studied at baseline and during local leg infusion of insulin alone (control, n=7) or insulin plus the nitric oxide synthase inhibitor NG-monomethyl-L-arginine (L-NMMA, n=7) to prevent insulin-induced vasodilation. METHODS: We measured skeletal muscle protein metabolism with stable isotope tracers, blood flow with indocyanine green, capillary recruitment with contrast enhanced ultrasound, glucose metabolism with stable isotope tracers, and phosphorylation of proteins associated with insulin (Akt) and amino acid-induced mammalian target of rapamycin (mTOR) complex 1 (mTORC1) signaling (mTOR, S6 kinase 1, and eukaryotic initiation factor 4E-binding protein 1) with Western blot analysis. RESULTS: No basal differences between groups were detected. During insulin infusion, blood flow and capillary recruitment increased in the control (P<0.05) group only; Akt phosphorylation and glucose uptake increased in both groups (P<0.05), with no group differences; and mTORC1 signaling increased more in control (P<0.05) than in L-NMMA. Phenylalanine net balance increased (P<0.05) in both groups, but with opposite mechanisms: increased protein synthesis (basal, 0.051+/-0.006 %/h; insulin, 0.077+/-0.008 %/h; P<0.05) with no change in proteolysis in control and decreased proteolysis (P<0.05) with no change in synthesis (basal, 0.061+/-0.004 %/h; insulin, 0.050+/-0.006 %/h; P value not significant) in L-NMMA. CONCLUSIONS: Endothelial-dependent vasodilation and the consequent increase in nutritive flow and mTORC1 signaling, rather than Akt signaling, are fundamental mechanisms by which insulin stimulates muscle protein synthesis in humans. Additionally, these data underscore that insulin modulates skeletal muscle proteolysis according to its effects on nutritive flow.
Authors: Lucy H Clerk; Michelle A Vincent; Jonathan R Lindner; Michael G Clark; Stephen Rattigan; Eugene J Barrett Journal: Diabetes Metab Res Rev Date: 2004 Jan-Feb Impact factor: 4.876
Authors: Krishna M Vasudevan; David A Barbie; Michael A Davies; Rosalia Rabinovsky; Chontelle J McNear; Jessica J Kim; Bryan T Hennessy; Hsiuyi Tseng; Panisa Pochanard; So Young Kim; Ian F Dunn; Anna C Schinzel; Peter Sandy; Sebastian Hoersch; Qing Sheng; Piyush B Gupta; Jesse S Boehm; Jan H Reiling; Serena Silver; Yiling Lu; Katherine Stemke-Hale; Bhaskar Dutta; Corwin Joy; Aysegul A Sahin; Ana Maria Gonzalez-Angulo; Ana Lluch; Lucia E Rameh; Tyler Jacks; David E Root; Eric S Lander; Gordon B Mills; William C Hahn; William R Sellers; Levi A Garraway Journal: Cancer Cell Date: 2009-07-07 Impact factor: 31.743
Authors: Tatiana Moro; Camille R Brightwell; Rachel R Deer; Ted G Graber; Elfego Galvan; Christopher S Fry; Elena Volpi; Blake B Rasmussen Journal: J Nutr Date: 2018-06-01 Impact factor: 4.798
Authors: Mary Ann Johnson; Johanna T Dwyer; Gordon L Jensen; Joshua W Miller; John R Speakman; Pamela Starke-Reed; Elena Volpi Journal: J Nutr Date: 2011-01-26 Impact factor: 4.798
Authors: Scott J Dankel; Kevin T Mattocks; Matthew B Jessee; Samuel L Buckner; J Grant Mouser; Jeremy P Loenneke Journal: Eur J Appl Physiol Date: 2017-08-03 Impact factor: 3.078
Authors: Scott J Dankel; J Grant Mouser; Matthew B Jessee; Kevin T Mattocks; Samuel L Buckner; Jeremy P Loenneke Journal: Eur J Appl Physiol Date: 2017-06-22 Impact factor: 3.078
Authors: Joshua P Nederveen; Tim Snijders; Sophie Joanisse; Christopher G Wavell; Cameron J Mitchell; Leeann M Johnston; Steven K Baker; Stuart M Phillips; Gianni Parise Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-11-09 Impact factor: 3.619
Authors: Alexandra Kiskini; Henrike M Hamer; Benjamin T Wall; Bart B L Groen; Anneke de Lange; Jaap A Bakker; Joan M G Senden; Lex B Verdijk; Luc J C van Loon Journal: Age (Dordr) Date: 2013-03-26